Women's Health - 2021 Agenda


Fertility I Menopause I Sexual Wellness

Thursday 13th May


11:00 CET 10:00 BST 05:00 ET

Spotlight Showcase

Callaly
Callaly is a British period care B Corp that invented the Tampliner® – the first significant tampon innovation in 80 years – awarded one of TIME’s Best Inventions of 2020. Fast Company named Callaly one of the Most Innovative Companies of 2021 and the Independent said Callaly are "revolutionising the multi-billion pound feminine care industry". Further clinical applications in IVF / drug delivery are in development, which has recently received US & European patent grant.

Thang Vo-Ta, CEO & Co-Founder, Callaly

Thang Vo-Ta, CEO & Co-Founder, Callaly


13:00 CET 12:00 BST 07:00 EDT

Women’s health investment priorities including “taboo tech”, growth markets, inclusivity and equality

Women’s health is gaining ground as an important market segment. But it still desperately needs more investment. This session looks at why women’s health is so lucrative and how it extends beyond Femtech to complex medical solutions. It also looks at how to stimulate investment in female founders and putting women’s health at the top of more VC agendas.

Helga Gebhardt, Digital Marketing Director, Consumer Goods & Essity Ventures, Essity
Lucanus Polagnoli, Co-Founder, Calm/Storm Ventures
Deepali Nangia, Co-Founder, Alma Angels
Maria Velissaris
, Managing Partner, SteelSky Ventures
Moderator: Angela Tyrrell, SVP, LSX

Helga Gebhardt, Digital Marketing Director, Consumer Goods & Essity Ventures, Essity    Lucanus Polagnoli, Co-Founder, Calm_Storm Ventures 300x   Deepali Nangia, Co-Founder, Alma Angels    Maria Velissaris, Managing Partner, SteelSky Ventures    Angela Tyrrell, SVP, LSX 300x


14:00 CET 13:00 BST 08:00 EDT

Why “sex stops at 50” is a load of nonsense and how to access the sexual wellbeing market for older adults

The sexual wellbeing market is growing quickly, but few innovators recognise the opportunity of marketing to adults in later life. Instead, the myth prevails that sex stops at fifty. Find out why that is a load of nonsense, what the real market opportunity is from older adults and how to access it.

Elizabeth Gazda, CEO, Embr Labs
Adam Lewis, Chief Executive Officer, Hot Octopuss
Jackie Marshall-Cyrus, Ageing Innovation Strategist
Moderator: Rachel Scherl, Founder and CEO, SPARK Solutions for Growth

Elizabeth Gazda, CEO, Embr Labs    Adam Lewis, Chief Executive Officer, Hot Octopuss    Jackie Marshall-Cyrus, Ageing Innovation Strategist    Rachel Scherl, Founder and CEO, SPARK Solutions for Growth


15:00 CET 14:00 BST 09:00 EDT

Ask the investors (EU)

Get in front of European investors in women’s health and female founders. This interactive roundtable-style session is designed for emerging brands to put their questions to and build relationships with investors in their space.

Investors include:
Lucanus Polagnoli, Co-Founder, Calm/Storm Ventures
Deepali Nangia, Co-Founder, Alma Angels

Lucanus Polagnoli, Co-Founder, Calm/Storm Ventures   Deepali Nangia, Co-Founder, Alma Angels


16:00 CET 15:00 BST 10:00 EDT

“Women’s health is global health” – seizing market opportunities in period care, incontinence and sexual wellbeing

Join some of the world’s most interesting SMEs tackling an array of women’s health concerns (including period care, incontinence and sexual wellbeing) for a look at how to launch a successful women’s health brand. They'll be talking about busting taboos, fund raising, product manufacturing, distribution and marketing as well as lots more.

Gloria Kolb, Co-Founder and CEO, Elidah
Frances Tang, Founder, Awkward Essentials
Daniella Peri, CEO, Yoppie
Arion Long, Founder and CEO, Femly
Moderator: Mary Gunn, COO, Health Decisions

Gloria Kolb, Co-Founder and CEO, Elidah    Frances Tang, Founder, Awkward Essentials    Daniella Peri, CEO, Yoppie    Arion Long, Founder and CEO, Femly    Mary Gunn, COO, Health Decisions


17:00 CET 16:00 BST 11:00 ET

How to build a consumer microbiome business

Consumers are wild about microbiome, but the field has hit some snags in developing consumer-facing business models. In this session, companies who have successfully developed a consumer-facing microbiome business address how to retain scientific integrity while delivering a commercially successful model, pitfalls to watch out for and how the consumer appetite is evolving post-pandemic.

Gregory Lambert, CEO and VP R&D, TargEDys
Kristofer Cook, Co-Founder and CEO, Carbiotix
Hana Janebdar, Co-Founder and CEO, Juno Bio
Veronika Oudova, Co-Founder and CEO, S-Biomedic
Moderator: Christian Roghi, Director of Strategic Alliances, CosmosID

Gregory Lambert, CEO & VP R&D, TargEDys 300x    Kristofer Cook, Chief Executive Officer, Carbiotix AB 300x    Hana Janebdar, CEO, Juno Bio 300x    Veronika Oudova, Co-Founder and CEO, S-Biomedic    Christian Roghi, Director of Strategic Alliances, CosmosID


18:00 CET 17:00 BST 12:00 EDT 9:00 PST

Ask the investors (US)

Get in front of US investors in women’s health and female founders. This interactive roundtable-style session is designed for emerging brands to put their questions to and build relationships with investors in their space.

Investors include:
Anula Jayasuriya, Founder and Managing Director, EXXclaim Capital
Maria Velissaris, Managing Partner, SteelSky Ventures

Anula Jayasuriya, Founder and Managing Director, EXXclaim Capital    Maria Velissaris, Managing Partner, SteelSky Ventures


19:00 CET 18:00 BST 13:00 EDT 10:00 PST

Menopause as a movement

Menopause is one of the most attractive and investible segments of the women’s health market. It’s a huge market offering limited solutions and is finally starting to cut through the taboo of old. Welcome to menopause as a movement! This session explores how emerging businesses are accessing the menopause market opportunity and creating the next big consumer trend in the meantime.

Kate Bache, Co-Founder and CEO, Health & Her
Rochelle Weitzner, Founder and CEO, The Pause Group
Peter Astbury, Founder, Astinno
Jill Angelo
, Founder and CEO, Gennev
Moderator: Alice Zheng, Women’s Health Practice Leader, McKinsey & Co

Kate Bache, Co-Founder and CEO, Health & Her    Rochelle Weitzner, Founder and CEO, The Pause Group    Peter Astbury, Founder, Astinno    Jill Angelo, Founder and CEO, Gennev    Alice Zheng, Engagement Manager, McKinsey & Co


20:00 CET 19:00 BST 14:00 EDT 11:00 PST

Commercialisation of pre- and post-natal health platforms

Conception, pregnancy, birth and post-natal recovery is all pretty run-of-the mill stuff, right? Said no woman ever! The number of reported pregnancy-related death in the US has increased from 7.2 per 100,000 births in 1987 to 17.3 per 100,000 births in 2017. We need to take pregnancy – including pre- and post-natal health – more seriously. This session looks at how assorted stakeholders are rising to the challenge, and how to do so commercially.

Melinda Nicci, Founder and CEO, Baby 2 Body
Carrie Yang, Founder, Gynii Me
Susan Nicholson, Vice President, Women’s Health, Johnson & Johnson
Moderator: Anula Jayasuriya, Founder and Managing Director, EXXclaim Capital

Melinda Nicci, Founder and CEO, Baby 2 Body    Carrie Yang, Founder, Gynii Me    Susan Nicholson, Vice President, Women’s Health, Johnson & Johnson    Anula Jayasuriya, Founder and Managing Director, EXXclaim Capital

 

DOWNLOAD BROCHURE